KELLY NELSON: Open Payments
NPI 1225736994 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,482 in 65 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $540 · 2025 $1,482
Food & beverage: $1,482
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $344 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $224 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $223 |
| GENZYME CORPORATION | 5 | $132 |
| Madrigal Pharmaceuticals | 6 | $120 |
| Ardelyx, Inc. | 3 | $91 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Ipsen Biopharmaceuticals, Inc | 3 | $65 |
| PFIZER INC. | 2 | $36 |
| ABBVIE INC. | 2 | $35 |
Products named: TREMFYA, XIFAXAN, ENTYVIO, DUPIXENT, REZDIFFRA, IBSRELA, IQIRVO, OMVOH.
Industry payments across MD — which companies pay providers there.
